The purpose of the Hospital of the University of Pennsylvania (HUP) postgraduate year one (PGY1) pharmacy residency program is to build on Doctor of Pharmacy (PharmD) education and outcomes to contribute to the development of clinical pharmacists responsible for medication-related care of patients with a wide range of conditions, eligible for board certification, and eligible for postgraduate year two (PGY2) pharmacy residency training.
The resident will structure their year by choosing a schedule consisting of calendar month-long rotations with eight required rotations and four elective rotations. In addition, there are several required longitudinal experiences described below:
Orientation (required, one month)
Orientation takes place during the month of July (and sometimes may extend through the first week of August). During the month, the resident is oriented to the residency program purpose, structure, competencies, goals, and objectives. Residents will be oriented to all required and elective rotations; PharmAcademic and the evaluation process; and the Residency Manual which contain all residency policies. During orientation, the resident will have the opportunity to meet the staff, preceptors, and leadership team through several welcome/ introductory activities.
The resident will also be oriented to the Department of Pharmacy. This training emphasizes the distributive functions of the hospital’s pharmacy, medication and departmental policies and procedures, and the skills required to serve as a clinical pharmacist during residency rotations and during clinical service requirements.
The resident will participate in an orientation to the Central Inpatient Pharmacy (CIP), the hospital's clinical information systems, departmental procedures, and the robotic unit dose systems. The resident will be introduced to the Sterile and Non-Sterile compounding areas, which will provide an overview of aseptic technique, chemotherapeutic handling, dosage calculations, USP797 guidelines, and specialty product preparation.
During the orientation rotation, the resident will also be trained to cover the pharmacokinetics consult service, respond to medical emergencies, and will be introduced to drug use evaluation (DUE) and research projects.
Medication Use Policy and Safety (required, one month)
The Medication Use Policy and Safety learning experience takes place in the Center for Medication Use Policy (CMUP) at the Hospital of the University of Pennsylvania. CMUP is staffed by several pharmacists who specialize in Drug Information and Medication Safety whom are responsible for:
Improving medication-use systems/policies through appropriate formulary management,
Contributing to the organization's evaluation of, and response to, medication errors and medication-related adverse events
Leading/ participating in medication use evaluations, reviewing order sets for clinical appropriateness
Identifying improvements to electronic medication-use systems that improve patient care and/or safety
Conducting quality improvement and research projects
Managing drug shortages and supply interruptions
Maintaining the drug libraries on all smart infusion pumps for the Health System and monitor medical and nursing compliance
Precepting pharmacy learners
During this required, month-long rotation, the resident will serve as a member of the Center for Medication Use Policy team and be a resource to the Hospital and Health System patients and staff. The resident will be responsible for responding to inquiries in the Drug Information center, participating in the review of medication errors and adverse events, and assisting in the drafting/review of medication use policies, guidelines, and order sets. The resident will be assigned formal written drug information responses, a formulary monograph, a formulary/category review a formulary guideline to review, a Drug Information clinical pearl/adverse drug evaluation bulletin, a medication safety related project, as well and other projects as needed. During the month the resident will attend the Pharmacy and Therapeutics Committee (P&T), and Medication Safety Committee meetings. The resident will be working on projects or reports for each of these committees. The resident will also be actively involved in planning and communication around current Drug Shortages through participation in the Drug Shortage Task Force.
Pharmacy Leadership (required, one month)
The Pharmacy Administration Leadership experience will introduce each resident to the activities required to operate and maintain a comprehensive pharmacy department comprised of over 300 employees, an overall pharmacy budget of over $250 million, and a broad scope of clinical, academic, research, and distributive services. The goals of this rotation are to expose the resident to health-system pharmacy leadership including organizational leadership and decision making, department planning, performance improvement, best practices, regulatory requirements, and department policies through reading and topic discussions, shadowing with department leaders, and active participation in a variety of projects and meetings. The resident will work with the Chief of Pharmacy for the entire Penn Medicine enterprise as well as other members of the leadership team.
Internal Medicine (required, one month)
This rotation is a direct patient-care experience in Internal Medicine, providing exposure to acute and chronic disease states, focusing on acute care management and transitioning patients to successful outpatient treatment. The role of the pharmacist is to perform the daily clinical responsibilities necessary to enhance the care of patients and education of the general medical team while balancing unit-based pharmacy responsibilities. This services will include, but not limited to: patient data collection, organization and assessment; development of therapeutic plans and corresponding monitoring for both efficacy and toxicity; communication with patients and caregivers to acquire necessary medication information, assess outcomes and provide education; verification of medication orders; communication with other health care providers to seek clarification and provide observations and recommendations consistent with the therapeutic plan; assuring medication reaches the patient; and provision of drug information to health care professionals in the hospital. Teaching responsibilities will include engaging with APPE students during topic discussions, patient presentation and other activities. Residents may choose to serve as the primary preceptor for one to APPE students during at least part of the rotation.
Critical Care (required, one month)
The Critical Care rotation is designed to provide the PGY1 resident with experience in providing pharmaceutical care for critically ill patients. The focus of the rotation will be on core intensive care unit (ICU) topics such as stress ulcer prophylaxis; venous thromboembolism (VTE) prophylaxis; glycemic control; pain, agitation, and delirium; hemodynamics; mechanical ventilation; rapid sequence intubation; Advanced Cardiac Life Support (ACLS) and clinical emergencies; pharmacokinetics and pharmacodynamics alterations in critically ill patients; acute kidney injury and continuous renal replacement therapies; and sepsis.
There are a total of 122 adult ICU beds at HUP: 32 medical, 12 cardiac, 22 neurological, 24 surgical, and 32 cardiothoracic/vascular surgery ICU beds. The resident has an opportunity to rotate in any of these ICU settings listed above. A team of pharmacists, including clinical pharmacy specialists in critical care medicine, provide care for the patients in each of these units. HUP is a tertiary care referral site supported by PENNSTAR 1 and 2 life flight helicopters, which respond as a primary resource for critical care transport. The ICU patient acuity is extremely high, and there are many opportunities for the pharmacy team to interact with the medical, nursing, respiratory, clinical nutrition, physical therapy, and occupational therapy team members. The pharmaceutical care provided to patients includes drug distribution, prospective evaluation of drug therapy, provision of drug information, prevention of medical errors, pharmacokinetic monitoring, education, development of critical pathways and drug utilization guidelines, patient-specific case management, and quality assurance initiatives. Management of critical illness, awareness of the unique considerations of the critically ill patient/family, and the ability to work with a closely aligned interdisciplinary professional staff are unique aspects of this practice site. The clinical pharmacy specialists have advanced degrees, residency training, and have been practicing critical care for several years.
Infectious Diseases (required, one month)
There are four different inpatient infectious diseases (ID) services at HUP: a general consult service, a solid organ transplant consult service, an HIV primary service, and an oncology consult service. First year residents are required to complete a rotation on the general ID consult service. This general ID consult service team consists of an ID attending, an ID fellow, medical residents, a pharmacy resident, and medical students. The other three services consist mainly of an ID attending with or without an ID fellow. The pharmacy resident participates in daily rounds to monitor patients’ therapies for efficacy and toxicity, to provide pharmacokinetic support, and to research any questions that arise. In addition, the pharmacy resident attends ID Management Conference, ID Grand Rounds, and the ID Fellows’ Journal Club. The rotation is precepted by four clinical pharmacy specialists with advanced degrees and residency training in infectious diseases.
Research (required, one month and longitudinal)
The Research experience is a systematic evaluation of an important and novel clinical question that seeks to improve knowledge directly or indirectly impacting patient care. This activity occurs through a structured program that is coordinated by the Pharmacy Research Committee at HUP. The majority of activities occur in a longitudinal fashion with the exception of a research month in December. The purpose of the Research program is to examine a clinically important research question. The purpose is also to provide the resident with a mentored research experience including active participation in the Epidemiology Series, which presents both a basic overview of the research experience and hands-on learning experiences such as statistical interpretation and database creation.
Basic research ideas will be generated by the clinical pharmacy staff in April or May prior to the new residency year in July. Proposal will be reviewed for appropriateness, feasibility, and impact by the Pharmacy Research Committee. Once approved, the research committees’ ideas will be presented to the residents. As a group, the residents will then choose their project, amongst themselves, based on their preferences. Following each residents receiving their research topic, the resident will then be assigned a research team. The research team will consist of the resident, a primary preceptor, and 1-3 secondary preceptors. The purpose of the research team is to allow for collaboration in order to assist the resident in developing details as it pertains to the research project and their research question. Throughout the process, the resident will be required to present aspects of the research to the Pharmacy Research Committee and a finalized presentation at The Eastern States Regional Conference.
Ambulatory Care (required, one month)
The learning activities are designed to give the resident a foundation in ambulatory care skills that can be used throughout the residency and in the resident's post-residency career. Pending preceptor availability, residents will be assigned to one of the following experiences: pulmonary/cystic fibrosis, infectious disease, neurology, oncology, or cardiology/anticoagulation.
The pharmacist is responsible for the annual review of each adult cystic fibrosis patient (>350 patients) seen at the lung center, in accordance with guidelines outlined by the grant awarded by the Cystic Fibrosis Foundation. Routine responsibilities include the following: medication reconciliation, drug interaction assessment and management/monitoring, drug selection/medication management, drug efficacy and safety monitoring, medication adherence assessment, monitoring and optimization, medication education, therapeutic drug monitoring of home intravenous antibiotics, and answering drug information questions. These actions are documented in the Pharmacy Annual Visit for cystic fibrosis patients.
Infectious disease (HIV/HCV):
The role of the pharmacist is to anticipate, review, or resolve medication-related problems for all patients in addition to ensuring safe and effective medication use for patients seen by the Infectious Disease Practice. Routine responsibilities include: medication reconciliation, drug interaction assessment and management/monitoring, drug selection/medication management, drug efficacy and safety monitoring. The pharmacist will also provide drug information and education to healthcare professionals as well patients and caregivers.
Residents primarily assist in the care of patients with HIV infection with polypharmacy and comorbidities, HCV treatment education and follow up, PrEP initiation education and monitoring.
The role of the pharmacist is to anticipate, review, or resolve medication-related problems for all patients in addition to ensuring safe and effective medication use for patients with Multiple Sclerosis. Routine responsibilities include: Counseling all new start patients or those switching their Disease Modifying Therapies (DMT), reconciling medication list, and performing drug interaction check (ex. reconciling medications for all patients referred to patient, drug interaction check, etc.). The pharmacist will also provide drug information and education to healthcare professionals as well patients and caregivers.
Pharmacists regularly work with the medical team to identify and resolve medication-related problems for all patients in the clinic and infusion suite. The focus of this rotation is placed on managing patients actively receiving chemotherapy/biotherapy (both oral and IV) and supportive care, with an increased focus on general management of the oncology patient and best supportive care measures.
Pharmacists initiate, monitor, and modify medication therapy to ensure patients are within their target INR goal. They also assist in developing anticoagulation plans for upcoming procedures by evaluating risk of bleeding and thrombosis for each patient. In addition, they serve as a consult service to outpatient practices to address questions related to anticoagulation therapy to provide recommendations to optimize patient outcomes, minimize safety issues, and ensure cost effectiveness. Lastly, they provide education to pharmacy students and residents through both didactic and hands-on experiences.
Solid Tumor Oncology
Allogeneic Hematopoietic Stem Cell Transplant and Cellular Therapy
Solid Organ Transplant
Pain and Palliative Care
Cardiac Intensive Care Unit
Investigational Drug Service
Neonatal Intensive Care
Unit Based Clinical Pharmacy
Required Longitudinal Experiences
Each PGY1 resident will cover at least four weeks of clinical on call throughout the year. During this week they will be on-call (not required to be on-site) from Monday-Friday from 4:00 pm- 11:00 pm and Saturday and Sunday from 8:00 am until 11:00 pm to answer any clinical questions posed by pharmacy staff members. The resident will be assigned a preceptor during on-call to assist them when needed. The performance of the resident during this week will be monitored by the preceptor, and feedback will be delivered verbally and documented in PharmAcademic.
Medication Use Evaluation (MUE)
The MUE experience is a quality improvement project focused primarily on the use of medications at the Hospital of the University of Pennsylvania. This activity occurs through a structured program that is coordinated by the Center for Medication Use Policy. Residents will collaborate with a group of preceptors to a complete a MUE. Residents select a project of interest from a list of topics approved by Pharmacy Leadership and the HUP P&T committee. Each topic promotes performance improvement involving medication or medication use processes designed to improve patient or institutional outcomes. Findings are presented to the Pharmacy Department and the HUP P&T Committee (and or one of its subcommittees).
Each resident will be expected to complete a formulary monograph to be presented to the UPHS and HUP P&T committees. The residents will receive an orientation to this process at the beginning of the year. The process is overseen by the Center for Medication Use policy which will assign the monograph, a preceptor, and presentation dates for each resident.
Therapeutics Conference/Grand Rounds
Each PGY1 resident is required to present 1 journal club and 2 patient case presentations as part of the Residency Program’s Therapeutics Conference
Each PGY1 resident is required to present 1 Grand Rounds, hour long CE presentation for the Pharmacy Department staff at Pharmacy Grand Rounds
Each PGY1 resident is assigned a Hospital or Health System committee to serve as a member of throughout the year. The purpose of this experience is to provide the resident with an understanding of how committees function and their role in the hospital or health system. resident is expected to attend all committee meetings and will be asked to prepare minutes for some of the meetings.
Other longitudinal experiences
Assist in mentoring and serving as a pharmacy role model to pharmacy students, other residents, and pharmacy staff
Act as an integral part of the team taking care of patients in both the inpatient and outpatient clinic settings by providing education to nurses, physicians, and patients
Actively participate in medication reconciliation at admission and discharge
Maintain certification in Basic Life Support (BLS) and ACLS
Respond medical emergencies including to code calls, urgent intubations, and rapid responses as assigned
Participate in the Pharmacoepidemiology Lecture Series
Present research protocol to the Pharmacy preceptor group and research subcommittee
Submit an abstract for poster presentation at the American Society of Health System Pharmacist (ASHP) Midyear Clinical Meeting
Formally present a completed research project at the Eastern States Residency Conference
Complete Medication Adherence consults for the Kidney Transplant service
Participate in the Teaching Certificate Program at the Philadelphia College of Pharmacy (optional)
Each resident is assigned a mentor. This mentor will assist the resident in strategically laying out the year and provide guidance, based on the resident’s career goals and interests. The mentor will also meet with the resident and RPD regularly to discuss the resident’s goals and to review all rotation evaluations. The mentor will assist in preparing the resident for their Grand Rounds and Eastern States presentations as well as for interviews.
PGY1 Residency Program Director
Danielle Auxer, PharmD Associate Director of Pharmacy, Medication Use Policy Hospital of the University of Pennsylvania 3400 Spruce Street Philadelphia, PA 19104 [email protected]
Graduate or candidates for graduation of an Accreditation Council for Pharmacy Education (ACPE) accredited degree program (or one in process of pursuing accreditation) or have a Foreign Pharmacy Graduate Equivalency Committee (FPGEC) certificate from the National Association of Boards of Pharmacy (NABP).
Eligible for licensure in Pennsylvania by June 28, 2020
About Hospital of the University of Pennsylvania PGY1 Pharmacy Residency Program